iX Biopharma taps growing trend in telemedicine to supply medication
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
PHARMACEUTICAL maker iX Biopharma has commenced the supply of the drugs Wafesil and Silcapvia to patients who have consulted their doctors through telemedicine in Australia, it said in a bourse filing on Tuesday.
The medicines, supplied to Australian pharmacies and available to patients by doctors' prescription, are for treating male erectile dysfunction.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
OCBC is said to emerge as lead bidder for HSBC Indonesia assets
Middle East-linked energy supply shocks put Asean Power Grid back in focus
Eurokars Group introduces rental car franchises Enterprise Rent-A-Car, National Car Rental, and Alamo to Singapore
